Scott Dunseth Myers, Director of Zentalis Pharmaceuticals ZNTL, has filed 4 purchases and 0 sales on the open market. The latest trade was on 06/16.

SM

SM

Scott Dunseth Myers

Director

Company

Zentalis Pharmaceuticals ZNTL

First filing

23/01/04

Trades

37 trades

Buys / sales

4 / 0

12-month net buying

No record

Last trade

06/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
DT Dynavax Technologies	Open-market buy	25/08/22	25/08/25	3,800 sh	$10.82	$41,116	+12.2%
Zentalis PharmaceuticalsZNTL	Open-market buy	25/04/30	25/04/30	21,000 sh	$1.40	$29,400	+8.1%
Viridian Therapeutics, Inc.\DEVRDN	Open-market buy	23/04/12	23/04/12	4,000 sh	$25.37	$101,480	+1.6%
Viridian Therapeutics, Inc.\DEVRDN	Open-market buy	23/03/13	23/03/13	5,500 sh	$29.15	$160,325	+2.2%